Reduced cost of managing exacerbations with stable dose treatment with salmeterol/fluticasone (SFC) compared with adjustable maintenance dosing (AMD) with formoterol/budesonide (FBC)

BACKGROUND: The high cost of asthma care is largely attributed to poor control of disease, in particular the treatment of exacerbations. METHOD: A 1-year, randomised, double blind, double dummy study in adult asthmatics currently receiving >500–1000mcg ICS or 200–500mcg ICS+LABA daily. Both AMD a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Prim Care Respir J
Hlavní autoři: Pieters, Willem R., Williams, Angela E., Follows, Richard
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2005
Témata:
Abstact
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6743588/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pcrj.2005.06.006
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky